BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 26309109)

  • 1. Attenuation of the pressor response to exogenous angiotensin by angiotensin receptor blockers and benazepril hydrochloride in clinically normal cats.
    Jenkins TL; Coleman AE; Schmiedt CW; Brown SA
    Am J Vet Res; 2015 Sep; 76(9):807-13. PubMed ID: 26309109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of angiotensin II-induced facilitation of sympathetic neurotransmission in the pithed rat: a comparison between losartan, irbesartan, telmisartan, and captopril.
    Balt JC; Mathy MJ; Pfaffendorf M; van Zwieten PA
    J Hypertens; 2001 Mar; 19(3):465-73. PubMed ID: 11288817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the AT1-receptor antagonists losartan, irbesartan, and telmisartan on angiotensin II-induced facilitation of sympathetic neurotransmission in the rat mesenteric artery.
    Balt JC; Mathy MJ; Nap A; Pfaffendorf M; van Zwieten PA
    J Cardiovasc Pharmacol; 2001 Jul; 38(1):141-8. PubMed ID: 11444497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Efficacy of Long-term Oral Treatment with Telmisartan and Benazepril in Cats with Chronic Kidney Disease.
    Sent U; Gössl R; Elliott J; Syme HM; Zimmering T
    J Vet Intern Med; 2015; 29(6):1479-87. PubMed ID: 26474314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypotensive effects of the angiotensin II antagonist telmisartan in conscious chronically-instrumented transgenic rats.
    van Meel JC; Redemann N; Haigh RM
    Arzneimittelforschung; 1996 Aug; 46(8):755-9. PubMed ID: 9125273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin II receptor blockers: equal or preferred substitutes for ACE inhibitors?
    Grossman E; Messerli FH; Neutel JM
    Arch Intern Med; 2000 Jul; 160(13):1905-11. PubMed ID: 10888965
    [No Abstract]   [Full Text] [Related]  

  • 7. Sympatholytic properties of several AT1-receptor antagonists in the isolated rabbit thoracic aorta.
    Nap A; Balt JC; Pfaffendorf M; Van Zwieten PA
    J Hypertens; 2002 Sep; 20(9):1821-8. PubMed ID: 12195125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the angiotensin converting enzyme inhibitor benazepril in cats with induced renal insufficiency.
    Brown SA; Brown CA; Jacobs G; Stiles J; Hendi RS; Wilson S
    Am J Vet Res; 2001 Mar; 62(3):375-83. PubMed ID: 11277203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacological potency of various AT(1) antagonists assessed by Schild regression technique in man.
    Belz GG; Breithaupt-Grögler K; Butzer R; Fuchs W; Hausdorf C; Mang C
    J Renin Angiotensin Aldosterone Syst; 2000 Dec; 1(4):336-41. PubMed ID: 11967820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin type 1 receptor blockers induce peroxisome proliferator-activated receptor-gamma activity.
    Schupp M; Janke J; Clasen R; Unger T; Kintscher U
    Circulation; 2004 May; 109(17):2054-7. PubMed ID: 15117841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telmisartan: a review of its use in hypertension.
    Sharpe M; Jarvis B; Goa KL
    Drugs; 2001; 61(10):1501-29. PubMed ID: 11558835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telmisartan and carotid intima-media thickness regression: a class effect of angiotensin-receptor blockers?
    Ntaios G; Savopoulos C; Hatzitolios A
    Hypertens Res; 2008 Dec; 31(12):2187-8, author reply 2188. PubMed ID: 19139608
    [No Abstract]   [Full Text] [Related]  

  • 13. In vitro and in vivo characterization of the activity of telmisartan: an insurmountable angiotensin II receptor antagonist.
    Maillard MP; Perregaux C; Centeno C; Stangier J; Wienen W; Brunner HR; Burnier M
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1089-95. PubMed ID: 12183667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuation of the blood pressure response to exogenous angiotensin I after oral administration of benazepril to healthy adult horses.
    Afonso T; Giguère S; Rapoport G; Brown SA; Coleman AE
    Equine Vet J; 2017 May; 49(3):358-362. PubMed ID: 27224673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of angiotensin II improves hyperthyroid induced abnormal atrial electrophysiological properties.
    Xiao P; Gao C; Fan J; Du H; Long Y; Yin Y
    Regul Pept; 2011 Aug; 169(1-3):31-8. PubMed ID: 21545815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose dual blockade of the renin-angiotensin system improves tubular status in non-diabetic proteinuric patients.
    Renke M; Tylicki L; Rutkowski P; Wojnarowski K; Lysiak-Szydlowska W; Rutkowski B
    Scand J Urol Nephrol; 2005; 39(6):511-7. PubMed ID: 16303729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diurnal blood pressure control in the optimal treatment of hypertension].
    Alföldi S
    Orv Hetil; 2003 May; 144(18 Suppl 1):895-7. PubMed ID: 12785233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of oral losartan and enalapril on local venous and systemic pressor responses to angiotensin I and II in healthy men.
    Goldberg MR; de Mey C; Wroblewski JM; Li Q; Schroeter V; Belz GG
    Clin Pharmacol Ther; 1996 Jan; 59(1):72-82. PubMed ID: 8549037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective effects of AT1 receptor antagonists after experimental ischemic stroke: what is important?
    Culman J; Jacob T; Schuster SO; Brolund-Spaether K; Brolund L; Cascorbi I; Zhao Y; Gohlke P
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Sep; 390(9):949-959. PubMed ID: 28669009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative angiotensin II receptor blockade in healthy volunteers: the importance of dosing.
    Maillard MP; Würzner G; Nussberger J; Centeno C; Burnier M; Brunner HR
    Clin Pharmacol Ther; 2002 Jan; 71(1):68-76. PubMed ID: 11823759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.